Moving Beyond JAK Inhibitors in Myeloproliferative Neoplasms
2 Visninger
• 07/29/23
0
0
Indlejre
administrator
Abonnenter
Naveen Pemmaraju, MD, discusses the need to move beyond JAK inhibition when treating patients with myeloproliferative neoplasms.
Vis mere
Facebook kommentarer
SORT BY-
Topkommentarer
-
Seneste kommentarer